Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from STE

STERIS Stock: Is STE Underperforming the Healthcare Sector?

STERIS has trailed the broader market over the past year, while Wall Street analysts remain cautiously optimistic about the company’s future prospects.

Barchart · Sep 16

STERIS Stock Outlook: Is Wall Street Bullish or Bearish?

STERIS has lagged behind the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

Barchart · Aug 26

STERIS' Quarterly Earnings Preview: What You Need to Know

STERIS will release its first-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.

Barchart · Jul 17

From analysis to the latest developments in health,
read the most diverse news in one place.

Is STERIS Stock Underperforming the Dow?

While STERIS has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart · Jun 15

Are Wall Street Analysts Predicting STERIS Stock Will Climb or Sink?

STERIS has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · May 26

STERIS Q4 Earnings Call Highlights

STERIS (NYSE:STE) reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027. Senior Vice P

MarketBeat · May 15

7 Stocks Worth Buying the Dip in Now... Or At Least Adding to Your Watchlist

While the S&P 500 notched another record close on Tuesday, 17 NYSE and Nasdaq Composite stocks fell to new 52-week lows. Here’s why the seven highest-priced names deserve a spot on your watchlist.

Barchart · May 6

Read news from The Economist, FT, and more,
with one subscription

STERIS' Q4 2026 Earnings: What to Expect

STERIS will release its fourth-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.

Barchart · Apr 22

Is STERIS Stock Underperforming the Nasdaq?

STERIS has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Mar 16

Is Wall Street Bullish or Bearish on STERIS Stock?

Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart · Feb 20

STERIS Earnings Preview: What to Expect

STERIS is set to report its third-quarter earnings soon, and analysts are anticipating a single-digit growth in its bottom line.

Barchart · Jan 8

Is STERIS Stock Outperforming the S&P 500?

STERIS has outperformed the S&P 500 over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Barchart · Dec 10, 2025

Are Wall Street Analysts Bullish on STERIS Stock?

Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart · Nov 20, 2025

What You Need to Know Ahead of STERIS’ Earnings Release

STERIS is scheduled to release its second-quarter results next month, and analysts are anticipating a robust double-digit increase in earnings.

Barchart · Oct 22, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Sep 17, 2025

How Is STERIS’ Stock Performance Compared to Other Medical Devices Stocks?

STERIS has outpaced its industry peers over the past year, and analysts are reasonably bullish on its future prospects.

Barchart · Aug 27, 2025

What Are Wall Street Analysts' Target Price for STERIS Stock?

While STERIS has underperformed the broader market over the past year, analysts are highly optimistic about the stock’s prospects.

Barchart · Jul 16, 2025

What to Expect From STERIS' Next Quarterly Earnings Report

STERIS is set to report its second-quarter results next month, and analysts are projecting a double-digit rise in earnings.

Barchart · Jun 18, 2025

STERIS Stock: Is STE Outperforming the Healthcare Sector?

STERIS has outpaced the broader healthcare sector over the past year and analysts are reasonably bullish on its future prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · May 27, 2025

STERIS Stock: Is Wall Street Bullish or Bearish?

Despite STERIS’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.

Barchart · Apr 28, 2025

What to Expect From STERIS’ Q4 2025 Earnings Report

STERIS is all geared to report its fourth-quarter results next month, and analysts project its earnings to increase by a single digit.

Barchart · Mar 24, 2025

Is STERIS Stock Underperforming the Dow?

Despite STERIS’ underperformance relative to Dow Jones over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart · Feb 26, 2025

STERIS Stock: Analyst Estimates & Ratings

STERIS has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

StockNews.com · Feb 21, 2025

3 Specialty Healthcare Providers Addressing Niche Markets

The healthcare industry is poised for growth driven by the rapid adoption of new and advanced medical technologies to enhance diagnosis. Hence, investors might consider investing in healthcare stocks, such as Agilent Technologies (A), BioNTech (BNTX), and STERIS (STE), which address niche markets. Read more….

Barchart · Jan 14, 2025

Here's What to Expect from STERIS’ Next Earnings Report

Healthcare major STERIS is expected to announce its third-quarter earnings in the upcoming month and analysts expect a modest single-digit growth in earnings.

Barchart · Dec 19, 2024

Is STERIS Stock Underperforming the Nasdaq?

STERIS stock has significantly underperformed the Nasdaq over the past 52 weeks, yet analysts remain strongly bullish on the stock’s prospects.

1 2

Organisations

Agilent Technologies Inc

22 stories

IHI

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.